1-26044436-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001004434.3(SLC30A2):āc.280C>Gā(p.Leu94Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,613,610 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001004434.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC30A2 | NM_001004434.3 | c.280C>G | p.Leu94Val | missense_variant | 3/8 | ENST00000374276.4 | |
SLC30A2 | NM_032513.5 | c.271+561C>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC30A2 | ENST00000374276.4 | c.280C>G | p.Leu94Val | missense_variant | 3/8 | 1 | NM_001004434.3 | P1 | |
SLC30A2 | ENST00000374278.7 | c.271+561C>G | intron_variant | 1 | |||||
SLC30A2 | ENST00000498060.1 | n.464C>G | non_coding_transcript_exon_variant | 2/3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000320 AC: 8AN: 249906Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135100
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461324Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 726918
GnomAD4 genome AF: 0.000112 AC: 17AN: 152286Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74452
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 10, 2024 | The c.280C>G (p.L94V) alteration is located in exon 3 (coding exon 3) of the SLC30A2 gene. This alteration results from a C to G substitution at nucleotide position 280, causing the leucine (L) at amino acid position 94 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at